Structure-based Virtual Screening to Get New Scaffold Inhibitors of the Ser/Thr Protein Kinase PknB from Mycobacterium tuberculosis

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|13|10|1012-1018

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.13, Iss.10, 2016-12, pp. : 1012-1018

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacophore Identification: The Case of the Ser/Thr Protein Phosphatase Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 6, 2006-06 ,pp. : 657-665

Bentham Science Publishers

Access to resources Recommend Favorite

Customizing G Protein-Coupled Receptor Models for Structure-Based Virtual Screening

By  

Current Pharmaceutical Design, Vol. 15, Iss. 35, 2009-12 ,pp. : 4026-4048

Bentham Science Publishers

Access to resources Recommend Favorite

Scouting Novel Protein Kinase A (PKA) Inhibitors by Using a Consensus Docking-Based Virtual Screening Approach

By  

Letters in Drug Design & Discovery, Vol. 6, Iss. 5, 2009-07 ,pp. : 327-336

Bentham Science Publishers

Access to resources Recommend Favorite

MolDock Applied to Structure-Based Virtual Screening

By  

Current Drug Targets, Vol. 11, Iss. 3, 2010-03 ,pp. : 327-334

Bentham Science Publishers

Access to resources Recommend Favorite

Virtual Screening in Structure-Based Drug Discovery

By  

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 7, 2004-09 ,pp. : 779-791

Bentham Science Publishers

Access to resources Recommend Favorite